Specialists have identified a genetic polymorphism that may be important in worsening of cognitive function and progression to Alzheimer’s disease (AD) in patients with subjective cognitive decline (SCD) or mild cognitive impairment (MCI).
Specialists have identified a genetic polymorphism that may be important in worsening of cognitive function and progression to Alzheimer’s disease (AD) in patients with subjective cognitive decline (SCD) or mild cognitive impairment (MCI).